Anne Libby
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mental Health Services | 11 | 2016 | 321 | 1.600 |
Why?
| Medicaid | 11 | 2024 | 409 | 1.570 |
Why?
| Financing, Organized | 4 | 2020 | 33 | 1.360 |
Why?
| Research Personnel | 5 | 2020 | 151 | 1.220 |
Why?
| Comparative Effectiveness Research | 4 | 2013 | 130 | 1.110 |
Why?
| Depressive Disorder, Major | 5 | 2009 | 302 | 1.000 |
Why?
| Indians, North American | 6 | 2008 | 570 | 0.960 |
Why?
| Substance-Related Disorders | 8 | 2008 | 946 | 0.940 |
Why?
| Nonprescription Drugs | 3 | 2016 | 68 | 0.910 |
Why?
| Biomedical Research | 5 | 2020 | 585 | 0.900 |
Why?
| Antidepressive Agents | 6 | 2015 | 195 | 0.860 |
Why?
| Managed Care Programs | 10 | 2011 | 134 | 0.820 |
Why?
| Mentoring | 3 | 2022 | 101 | 0.790 |
Why?
| Sex Factors | 7 | 2022 | 1721 | 0.790 |
Why?
| Faculty, Medical | 4 | 2022 | 232 | 0.790 |
Why?
| Depressive Disorder | 6 | 2015 | 333 | 0.780 |
Why?
| Mental Disorders | 5 | 2017 | 897 | 0.720 |
Why?
| Interdisciplinary Research | 1 | 2020 | 25 | 0.700 |
Why?
| Sex Characteristics | 3 | 2022 | 635 | 0.670 |
Why?
| United States Food and Drug Administration | 4 | 2009 | 172 | 0.610 |
Why?
| Emergency Services, Psychiatric | 1 | 2017 | 33 | 0.580 |
Why?
| Child Welfare | 4 | 2007 | 192 | 0.580 |
Why?
| Academic Medical Centers | 3 | 2020 | 412 | 0.570 |
Why?
| Writing | 1 | 2018 | 85 | 0.560 |
Why?
| Interdisciplinary Studies | 1 | 2016 | 27 | 0.550 |
Why?
| Child Abuse | 6 | 2008 | 451 | 0.550 |
Why?
| Mentors | 5 | 2022 | 158 | 0.540 |
Why?
| United States | 30 | 2024 | 12227 | 0.540 |
Why?
| Prescription Drugs | 2 | 2016 | 116 | 0.530 |
Why?
| Academies and Institutes | 1 | 2016 | 44 | 0.530 |
Why?
| Science | 1 | 2016 | 48 | 0.510 |
Why?
| Contract Services | 3 | 2002 | 10 | 0.500 |
Why?
| Capitation Fee | 4 | 2002 | 13 | 0.490 |
Why?
| Health Policy | 5 | 2016 | 334 | 0.490 |
Why?
| Quality-Adjusted Life Years | 3 | 2014 | 101 | 0.470 |
Why?
| Colorado | 16 | 2020 | 4089 | 0.470 |
Why?
| Child Abuse, Sexual | 3 | 2007 | 82 | 0.470 |
Why?
| Length of Stay | 2 | 2017 | 951 | 0.470 |
Why?
| Health Care Costs | 2 | 2010 | 381 | 0.460 |
Why?
| Humans | 74 | 2024 | 115052 | 0.460 |
Why?
| Cooperative Behavior | 1 | 2016 | 383 | 0.450 |
Why?
| Dibenzothiazepines | 1 | 2013 | 17 | 0.450 |
Why?
| Adolescent | 32 | 2017 | 17866 | 0.450 |
Why?
| Data Collection | 5 | 2012 | 623 | 0.440 |
Why?
| Antihypertensive Agents | 3 | 2024 | 430 | 0.440 |
Why?
| Fee-for-Service Plans | 4 | 2002 | 83 | 0.440 |
Why?
| Medication Therapy Management | 1 | 2014 | 67 | 0.440 |
Why?
| Cohort Studies | 13 | 2016 | 4904 | 0.430 |
Why?
| Videoconferencing | 2 | 2017 | 57 | 0.420 |
Why?
| Suicide, Attempted | 3 | 2015 | 314 | 0.420 |
Why?
| Female | 47 | 2022 | 59619 | 0.420 |
Why?
| Physicians | 4 | 2022 | 772 | 0.410 |
Why?
| Male | 44 | 2022 | 55737 | 0.400 |
Why?
| Cities | 1 | 2012 | 81 | 0.390 |
Why?
| Pharmacists | 1 | 2014 | 236 | 0.390 |
Why?
| Income | 1 | 2012 | 167 | 0.390 |
Why?
| Antipsychotic Agents | 1 | 2013 | 184 | 0.390 |
Why?
| Depression | 3 | 2014 | 1136 | 0.370 |
Why?
| Unemployment | 1 | 2010 | 39 | 0.360 |
Why?
| Cost of Illness | 1 | 2012 | 254 | 0.360 |
Why?
| Plant Preparations | 1 | 2010 | 23 | 0.350 |
Why?
| Child, Preschool | 14 | 2017 | 9093 | 0.340 |
Why?
| Middle Aged | 28 | 2022 | 26831 | 0.340 |
Why?
| Research Support as Topic | 3 | 2020 | 108 | 0.340 |
Why?
| Telemedicine | 1 | 2017 | 665 | 0.330 |
Why?
| Cost-Benefit Analysis | 6 | 2017 | 544 | 0.330 |
Why?
| Tobacco Smoke Pollution | 1 | 2012 | 217 | 0.330 |
Why?
| Prescriptions | 1 | 2009 | 60 | 0.320 |
Why?
| Epilepsy | 1 | 2012 | 278 | 0.320 |
Why?
| Point-of-Care Systems | 1 | 2010 | 139 | 0.320 |
Why?
| Premature Birth | 1 | 2012 | 277 | 0.310 |
Why?
| Child | 23 | 2017 | 18409 | 0.310 |
Why?
| Stress Disorders, Post-Traumatic | 2 | 2007 | 757 | 0.300 |
Why?
| Health Maintenance Organizations | 2 | 2005 | 94 | 0.300 |
Why?
| Chronic Disease | 2 | 2013 | 1591 | 0.300 |
Why?
| Parents | 3 | 2017 | 1190 | 0.290 |
Why?
| Cross-Sectional Studies | 7 | 2017 | 4411 | 0.290 |
Why?
| Combat Disorders | 1 | 2007 | 33 | 0.290 |
Why?
| Drug and Narcotic Control | 1 | 2007 | 29 | 0.280 |
Why?
| Research Design | 3 | 2019 | 930 | 0.280 |
Why?
| Substance Withdrawal Syndrome | 1 | 2009 | 159 | 0.280 |
Why?
| Interview, Psychological | 1 | 2007 | 89 | 0.280 |
Why?
| Adult | 25 | 2019 | 30658 | 0.280 |
Why?
| Education, Medical | 2 | 2020 | 221 | 0.280 |
Why?
| Multivariate Analysis | 5 | 2017 | 1435 | 0.270 |
Why?
| Decision Making | 1 | 2013 | 782 | 0.270 |
Why?
| Diabetes Mellitus | 2 | 2014 | 906 | 0.270 |
Why?
| Health Behavior | 1 | 2012 | 704 | 0.270 |
Why?
| Juvenile Delinquency | 2 | 2004 | 103 | 0.260 |
Why?
| Retrospective Studies | 12 | 2016 | 12548 | 0.260 |
Why?
| Hypoglycemia | 1 | 2010 | 386 | 0.260 |
Why?
| Rural Population | 2 | 2007 | 446 | 0.250 |
Why?
| Longitudinal Studies | 7 | 2016 | 2389 | 0.250 |
Why?
| Stress, Psychological | 2 | 2010 | 946 | 0.250 |
Why?
| Aged | 18 | 2024 | 19122 | 0.250 |
Why?
| Family | 2 | 2006 | 591 | 0.250 |
Why?
| Suicide | 3 | 2007 | 502 | 0.250 |
Why?
| Ambulatory Care | 4 | 2014 | 478 | 0.250 |
Why?
| Curriculum | 3 | 2020 | 843 | 0.240 |
Why?
| Smoking | 1 | 2012 | 1392 | 0.240 |
Why?
| Parenting | 1 | 2008 | 251 | 0.240 |
Why?
| Aged, 80 and over | 8 | 2015 | 6357 | 0.240 |
Why?
| Practice Patterns, Physicians' | 4 | 2007 | 1178 | 0.230 |
Why?
| Crime | 1 | 2004 | 59 | 0.230 |
Why?
| Electronic Health Records | 3 | 2015 | 799 | 0.220 |
Why?
| Infant | 9 | 2017 | 7946 | 0.210 |
Why?
| Hypoglycemic Agents | 1 | 2010 | 1008 | 0.210 |
Why?
| Foster Home Care | 1 | 2003 | 70 | 0.200 |
Why?
| Brain Injuries | 2 | 2005 | 452 | 0.200 |
Why?
| Anxiety Disorders | 1 | 2005 | 307 | 0.200 |
Why?
| Residential Treatment | 1 | 2002 | 31 | 0.200 |
Why?
| Adolescent Psychiatry | 1 | 2002 | 12 | 0.200 |
Why?
| Logistic Models | 6 | 2017 | 1839 | 0.200 |
Why?
| Contracts | 1 | 2001 | 9 | 0.190 |
Why?
| Child Psychiatry | 1 | 2002 | 31 | 0.190 |
Why?
| Criminal Law | 1 | 2002 | 28 | 0.190 |
Why?
| Hypertension | 2 | 2022 | 1058 | 0.190 |
Why?
| Health Surveys | 3 | 2010 | 443 | 0.190 |
Why?
| Costs and Cost Analysis | 3 | 2010 | 196 | 0.190 |
Why?
| Schizophrenia | 1 | 2005 | 416 | 0.190 |
Why?
| Severity of Illness Index | 6 | 2014 | 2551 | 0.190 |
Why?
| Hospitals, Pediatric | 2 | 2017 | 477 | 0.190 |
Why?
| Young Adult | 10 | 2017 | 10498 | 0.190 |
Why?
| Health Services Accessibility | 2 | 2007 | 765 | 0.180 |
Why?
| Surface Plasmon Resonance | 1 | 2021 | 81 | 0.180 |
Why?
| Women's Health | 2 | 2020 | 271 | 0.180 |
Why?
| Dried Blood Spot Testing | 1 | 2021 | 72 | 0.180 |
Why?
| Organophosphates | 1 | 2021 | 90 | 0.170 |
Why?
| Organizational Innovation | 2 | 2020 | 133 | 0.170 |
Why?
| Education | 1 | 2020 | 95 | 0.170 |
Why?
| Population Groups | 3 | 2017 | 57 | 0.170 |
Why?
| Suicidal Ideation | 2 | 2015 | 397 | 0.160 |
Why?
| Adenine | 1 | 2021 | 220 | 0.160 |
Why?
| Interdisciplinary Communication | 1 | 2020 | 185 | 0.160 |
Why?
| Hospitalization | 2 | 2011 | 1755 | 0.160 |
Why?
| Health Services Research | 3 | 2016 | 371 | 0.150 |
Why?
| Gender Identity | 1 | 2019 | 101 | 0.150 |
Why?
| Foundations | 1 | 2018 | 22 | 0.150 |
Why?
| Caregivers | 2 | 2020 | 712 | 0.150 |
Why?
| Program Evaluation | 5 | 2021 | 825 | 0.150 |
Why?
| Sexism | 1 | 2018 | 43 | 0.150 |
Why?
| Hospital Costs | 2 | 2012 | 103 | 0.150 |
Why?
| Chi-Square Distribution | 3 | 2012 | 498 | 0.150 |
Why?
| Program Development | 1 | 2019 | 346 | 0.140 |
Why?
| Dose-Response Relationship, Drug | 2 | 2013 | 1857 | 0.140 |
Why?
| Attitude to Health | 2 | 2017 | 405 | 0.140 |
Why?
| Leadership | 1 | 2020 | 295 | 0.140 |
Why?
| Risk Factors | 8 | 2012 | 8642 | 0.140 |
Why?
| Veterans | 1 | 2007 | 1238 | 0.130 |
Why?
| Public Health Administration | 1 | 1997 | 76 | 0.130 |
Why?
| Reminder Systems | 1 | 2017 | 161 | 0.130 |
Why?
| Alcoholism | 1 | 2002 | 716 | 0.130 |
Why?
| Immunization | 1 | 2017 | 400 | 0.120 |
Why?
| Comorbidity | 3 | 2015 | 1457 | 0.120 |
Why?
| Accidents | 2 | 2005 | 38 | 0.120 |
Why?
| Community Mental Health Services | 2 | 2007 | 84 | 0.120 |
Why?
| Interviews as Topic | 2 | 2020 | 584 | 0.110 |
Why?
| Polypharmacy | 1 | 2014 | 74 | 0.110 |
Why?
| Quetiapine Fumarate | 1 | 2013 | 22 | 0.110 |
Why?
| Oregon | 1 | 2013 | 66 | 0.110 |
Why?
| Decision Support Techniques | 2 | 2014 | 351 | 0.110 |
Why?
| Patient Satisfaction | 1 | 2017 | 580 | 0.110 |
Why?
| Health Information Management | 1 | 2013 | 7 | 0.110 |
Why?
| Health Expenditures | 2 | 2006 | 171 | 0.110 |
Why?
| Minority Groups | 2 | 2022 | 228 | 0.110 |
Why?
| Age Factors | 5 | 2012 | 2894 | 0.110 |
Why?
| Statistics, Nonparametric | 1 | 2014 | 387 | 0.110 |
Why?
| Alcohol-Related Disorders | 2 | 2005 | 113 | 0.110 |
Why?
| Referral and Consultation | 1 | 2017 | 633 | 0.110 |
Why?
| Medical Audit | 1 | 2013 | 75 | 0.110 |
Why?
| Prevalence | 3 | 2011 | 2255 | 0.100 |
Why?
| Regression Analysis | 3 | 2011 | 948 | 0.100 |
Why?
| Medical Records Systems, Computerized | 1 | 2013 | 90 | 0.100 |
Why?
| Analysis of Variance | 2 | 2014 | 1229 | 0.100 |
Why?
| Women's Health Services | 2 | 2006 | 15 | 0.100 |
Why?
| Evidence-Based Medicine | 1 | 2016 | 676 | 0.100 |
Why?
| Economics, Pharmaceutical | 1 | 2012 | 10 | 0.100 |
Why?
| Diagnostic Tests, Routine | 1 | 2013 | 87 | 0.100 |
Why?
| Education, Pharmacy, Graduate | 1 | 2012 | 21 | 0.100 |
Why?
| Education, Graduate | 1 | 2012 | 30 | 0.100 |
Why?
| Efficiency | 1 | 2012 | 84 | 0.100 |
Why?
| Self Care | 1 | 2014 | 351 | 0.100 |
Why?
| Advisory Committees | 3 | 2007 | 208 | 0.100 |
Why?
| Chemoembolization, Therapeutic | 1 | 2012 | 47 | 0.100 |
Why?
| Health Services | 1 | 2012 | 103 | 0.100 |
Why?
| Maternal Age | 1 | 2012 | 117 | 0.100 |
Why?
| Patient-Centered Care | 1 | 2016 | 474 | 0.100 |
Why?
| Nausea | 1 | 2011 | 102 | 0.100 |
Why?
| Hospitals, University | 1 | 2012 | 170 | 0.100 |
Why?
| Infant, Small for Gestational Age | 1 | 2012 | 76 | 0.100 |
Why?
| Primary Health Care | 3 | 2010 | 1512 | 0.100 |
Why?
| State Health Plans | 2 | 2002 | 32 | 0.090 |
Why?
| Psychomotor Agitation | 1 | 2011 | 66 | 0.090 |
Why?
| Employment | 1 | 2012 | 139 | 0.090 |
Why?
| Sexual Dysfunction, Physiological | 1 | 2011 | 60 | 0.090 |
Why?
| Vomiting | 1 | 2011 | 124 | 0.090 |
Why?
| Medicare | 3 | 2024 | 666 | 0.090 |
Why?
| Insurance, Health, Reimbursement | 1 | 2012 | 88 | 0.090 |
Why?
| Interinstitutional Relations | 1 | 2011 | 55 | 0.090 |
Why?
| Radiography, Interventional | 1 | 2012 | 111 | 0.090 |
Why?
| Social Support | 2 | 2020 | 528 | 0.090 |
Why?
| Headache | 1 | 2011 | 131 | 0.090 |
Why?
| Policy Making | 1 | 2011 | 81 | 0.090 |
Why?
| Drug Labeling | 2 | 2007 | 42 | 0.090 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2011 | 99 | 0.090 |
Why?
| Computer Communication Networks | 1 | 2010 | 32 | 0.090 |
Why?
| Heart Transplantation | 1 | 2016 | 669 | 0.090 |
Why?
| Carcinoma, Hepatocellular | 1 | 2012 | 218 | 0.090 |
Why?
| Influenza, Human | 2 | 2017 | 546 | 0.090 |
Why?
| Medication Adherence | 1 | 2014 | 537 | 0.090 |
Why?
| Residence Characteristics | 1 | 2012 | 275 | 0.090 |
Why?
| Proportional Hazards Models | 3 | 2015 | 1080 | 0.090 |
Why?
| Life Style | 1 | 2012 | 431 | 0.080 |
Why?
| California | 3 | 2007 | 364 | 0.080 |
Why?
| Vaccination | 1 | 2017 | 1205 | 0.080 |
Why?
| Surveys and Questionnaires | 4 | 2020 | 4631 | 0.080 |
Why?
| Information Dissemination | 1 | 2011 | 188 | 0.080 |
Why?
| Drug Utilization Review | 1 | 2009 | 57 | 0.080 |
Why?
| Prospective Studies | 3 | 2021 | 6232 | 0.080 |
Why?
| Financing, Government | 2 | 2000 | 40 | 0.080 |
Why?
| HIV Infections | 2 | 2021 | 2470 | 0.080 |
Why?
| Catheter Ablation | 1 | 2012 | 291 | 0.080 |
Why?
| Drug Prescriptions | 2 | 2007 | 239 | 0.080 |
Why?
| Community-Institutional Relations | 1 | 2009 | 89 | 0.080 |
Why?
| Absorptiometry, Photon | 1 | 2009 | 223 | 0.080 |
Why?
| Liver Neoplasms | 1 | 2012 | 516 | 0.070 |
Why?
| Databases, Factual | 4 | 2016 | 1132 | 0.070 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2007 | 38 | 0.070 |
Why?
| Office Visits | 1 | 2007 | 79 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2009 | 719 | 0.070 |
Why?
| Infant, Newborn | 4 | 2012 | 5040 | 0.070 |
Why?
| Trauma Severity Indices | 2 | 2005 | 111 | 0.070 |
Why?
| Sleep | 1 | 2011 | 631 | 0.070 |
Why?
| Drug Utilization | 1 | 2007 | 167 | 0.070 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 231 | 0.070 |
Why?
| Alcohol Drinking | 1 | 2012 | 655 | 0.070 |
Why?
| Parent-Child Relations | 1 | 2008 | 234 | 0.060 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2005 | 35 | 0.060 |
Why?
| Pilot Projects | 1 | 2010 | 1375 | 0.060 |
Why?
| Physicians, Family | 1 | 2007 | 201 | 0.060 |
Why?
| Pregnancy | 2 | 2020 | 5520 | 0.060 |
Why?
| Cost Savings | 2 | 2012 | 74 | 0.060 |
Why?
| Bone Density | 1 | 2009 | 432 | 0.060 |
Why?
| Psychiatry | 1 | 2007 | 155 | 0.060 |
Why?
| Quality of Life | 1 | 2015 | 2360 | 0.060 |
Why?
| Qualitative Research | 2 | 2020 | 935 | 0.060 |
Why?
| Treatment Outcome | 3 | 2013 | 9123 | 0.060 |
Why?
| Northwestern United States | 1 | 2004 | 53 | 0.060 |
Why?
| Florida | 1 | 2024 | 73 | 0.060 |
Why?
| Southwestern United States | 1 | 2004 | 91 | 0.060 |
Why?
| Age of Onset | 1 | 2005 | 449 | 0.060 |
Why?
| Direct Service Costs | 1 | 2003 | 10 | 0.060 |
Why?
| Brain Damage, Chronic | 1 | 2003 | 19 | 0.060 |
Why?
| Volition | 1 | 2003 | 31 | 0.060 |
Why?
| Physician-Patient Relations | 1 | 2007 | 463 | 0.050 |
Why?
| Odds Ratio | 2 | 2004 | 957 | 0.050 |
Why?
| Monte Carlo Method | 2 | 2014 | 137 | 0.050 |
Why?
| Tobacco Use Disorder | 1 | 2005 | 236 | 0.050 |
Why?
| Marijuana Abuse | 1 | 2005 | 212 | 0.050 |
Why?
| Sampling Studies | 1 | 2003 | 94 | 0.050 |
Why?
| Somatoform Disorders | 1 | 2003 | 37 | 0.050 |
Why?
| Angiotensin Receptor Antagonists | 1 | 2022 | 76 | 0.050 |
Why?
| Rehabilitation, Vocational | 1 | 2002 | 2 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2022 | 115 | 0.050 |
Why?
| Case-Control Studies | 1 | 2009 | 3015 | 0.050 |
Why?
| Cost Allocation | 1 | 2002 | 7 | 0.050 |
Why?
| Factor Analysis, Statistical | 1 | 2003 | 257 | 0.050 |
Why?
| Child Health Services | 2 | 2001 | 176 | 0.050 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 180 | 0.050 |
Why?
| Reimbursement, Incentive | 1 | 2002 | 35 | 0.050 |
Why?
| Immunity | 1 | 2022 | 121 | 0.050 |
Why?
| Practice Management, Medical | 1 | 2001 | 34 | 0.050 |
Why?
| Data Interpretation, Statistical | 1 | 2003 | 323 | 0.050 |
Why?
| Confidence Intervals | 1 | 2002 | 306 | 0.050 |
Why?
| Adrenergic beta-Antagonists | 1 | 2022 | 294 | 0.050 |
Why?
| Emergency Medical Services | 1 | 2007 | 587 | 0.040 |
Why?
| Occupational Diseases | 1 | 2002 | 128 | 0.040 |
Why?
| Adolescent Behavior | 1 | 2005 | 488 | 0.040 |
Why?
| International Classification of Diseases | 2 | 2015 | 116 | 0.040 |
Why?
| Pediatrics | 1 | 2007 | 981 | 0.040 |
Why?
| Models, Statistical | 1 | 2003 | 602 | 0.040 |
Why?
| Social Stigma | 1 | 2020 | 87 | 0.040 |
Why?
| Risk Assessment | 3 | 2015 | 2976 | 0.040 |
Why?
| Carcinoma, Ductal, Breast | 1 | 1999 | 76 | 0.040 |
Why?
| Health Care Surveys | 2 | 1997 | 538 | 0.040 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3247 | 0.040 |
Why?
| Career Choice | 1 | 2019 | 181 | 0.040 |
Why?
| Blood Pressure | 1 | 2024 | 1539 | 0.040 |
Why?
| Competitive Bidding | 1 | 1997 | 3 | 0.040 |
Why?
| Decision Making, Organizational | 1 | 1997 | 22 | 0.040 |
Why?
| Administrative Personnel | 1 | 1997 | 29 | 0.040 |
Why?
| Motivation | 1 | 2001 | 498 | 0.040 |
Why?
| Pneumococcal Infections | 1 | 2017 | 91 | 0.030 |
Why?
| Specialization | 2 | 2007 | 115 | 0.030 |
Why?
| Pneumococcal Vaccines | 1 | 2017 | 132 | 0.030 |
Why?
| National Institute of Mental Health (U.S.) | 1 | 2016 | 4 | 0.030 |
Why?
| Models, Organizational | 1 | 1997 | 140 | 0.030 |
Why?
| Medicine | 2 | 2007 | 102 | 0.030 |
Why?
| Focus Groups | 1 | 2017 | 385 | 0.030 |
Why?
| Citalopram | 1 | 2015 | 27 | 0.030 |
Why?
| Immunization Programs | 1 | 2017 | 206 | 0.030 |
Why?
| Fluoxetine | 1 | 2015 | 46 | 0.030 |
Why?
| Clinical Protocols | 1 | 2016 | 234 | 0.030 |
Why?
| Urban Population | 1 | 1997 | 401 | 0.030 |
Why?
| Uncertainty | 1 | 2014 | 95 | 0.030 |
Why?
| Treatment Failure | 1 | 2015 | 332 | 0.030 |
Why?
| Reoperation | 1 | 2016 | 519 | 0.030 |
Why?
| Probability | 1 | 2014 | 289 | 0.030 |
Why?
| American Recovery and Reinvestment Act | 1 | 2013 | 6 | 0.030 |
Why?
| Insurance Claim Review | 1 | 2013 | 67 | 0.030 |
Why?
| Influenza Vaccines | 1 | 2017 | 496 | 0.030 |
Why?
| Adenocarcinoma | 1 | 1999 | 795 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2015 | 955 | 0.030 |
Why?
| Linear Models | 1 | 2014 | 776 | 0.030 |
Why?
| Diabetes Complications | 1 | 2014 | 212 | 0.020 |
Why?
| Schools, Pharmacy | 1 | 2012 | 52 | 0.020 |
Why?
| Databases as Topic | 1 | 2011 | 63 | 0.020 |
Why?
| Decision Trees | 1 | 2012 | 81 | 0.020 |
Why?
| Models, Economic | 1 | 2012 | 48 | 0.020 |
Why?
| Faculty | 1 | 2012 | 130 | 0.020 |
Why?
| Radiotherapy | 1 | 2012 | 176 | 0.020 |
Why?
| Health Care Rationing | 1 | 2011 | 45 | 0.020 |
Why?
| Propensity Score | 1 | 2011 | 224 | 0.020 |
Why?
| Patient Discharge | 1 | 2016 | 767 | 0.020 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 139 | 0.020 |
Why?
| Legislation, Medical | 1 | 2007 | 10 | 0.020 |
Why?
| Poverty Areas | 1 | 2007 | 32 | 0.020 |
Why?
| Crisis Intervention | 1 | 2007 | 29 | 0.020 |
Why?
| Breast Neoplasms | 1 | 1999 | 1865 | 0.020 |
Why?
| Computer Simulation | 1 | 2012 | 881 | 0.020 |
Why?
| Students | 1 | 2012 | 499 | 0.020 |
Why?
| Appointments and Schedules | 1 | 2007 | 72 | 0.020 |
Why?
| Drug Monitoring | 1 | 2007 | 184 | 0.020 |
Why?
| Least-Squares Analysis | 1 | 2006 | 73 | 0.020 |
Why?
| Ontario | 1 | 2006 | 75 | 0.020 |
Why?
| Time Factors | 1 | 2016 | 6142 | 0.020 |
Why?
| Osteoporosis | 1 | 2009 | 225 | 0.020 |
Why?
| Health Status Indicators | 1 | 2006 | 154 | 0.020 |
Why?
| Seasons | 1 | 2007 | 448 | 0.020 |
Why?
| Pandemics | 1 | 2011 | 1322 | 0.010 |
Why?
| Hospital Mortality | 1 | 2005 | 777 | 0.010 |
Why?
| Multicenter Studies as Topic | 1 | 2002 | 250 | 0.010 |
Why?
| Physician Incentive Plans | 1 | 2000 | 6 | 0.010 |
Why?
| Cost Control | 1 | 2000 | 38 | 0.010 |
Why?
| Adolescent Health Services | 1 | 2001 | 68 | 0.010 |
Why?
| Workplace | 1 | 2002 | 220 | 0.010 |
Why?
| Health Care Reform | 1 | 2000 | 92 | 0.010 |
Why?
| Primary Prevention | 1 | 2000 | 171 | 0.010 |
Why?
| Incidence | 1 | 2005 | 2318 | 0.010 |
Why?
| Interpersonal Relations | 1 | 2002 | 339 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2007 | 4420 | 0.010 |
Why?
| Adenocarcinoma, Mucinous | 1 | 1999 | 61 | 0.010 |
Why?
| Lymphatic Metastasis | 1 | 1999 | 275 | 0.010 |
Why?
| Quality Indicators, Health Care | 1 | 2000 | 287 | 0.010 |
Why?
| Disease-Free Survival | 1 | 1999 | 617 | 0.010 |
Why?
| Patient Care Team | 1 | 2002 | 515 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2002 | 1215 | 0.010 |
Why?
| Prognosis | 1 | 1999 | 3335 | 0.010 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) Derived automatically from this person's publications. _
Co-Authors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People whose addresses are nearby this person. _
|